Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Rasagilin (ATC-Code: N04BD02).

Conclusion of a non-exclusive rebate contract in accordance with Section 130a, Paragraph 8, SGB V for medicinal products with the active substance Rasagiline (ATC Code: N04BD02) for the period from 01.10.2026 to 30.09.2028, with the possibility of concluding the contract at any time during the term ("open-house model").